The identification of combinations for the CDK4 and CDK6 inhibitor, abemaciclib

被引：0
|
作者：
Gong Xueqian
Chio, Li-Chun
Webster, Yue
Lallena, Maria Jose
Boehnke, Karsten
Torres, Raquel
Iversen, Phil
De Dios, Alfonso
Smith, Ian
Reinhard, Christoph
Peng, Sheng-Bin
Dempsey, Jack
Burke, Teresa
Chen, Shih-Hsun
Stewart, Trent
Beckmann, Richard
Wu, Wenjuan
Buchanan, Sean G.
机构：
来源：
MOLECULAR CANCER RESEARCH | 2016年 / 14卷
关键词：
D O I：
10.1158/1557-3125.CELLCYCLE16-A07
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A07
引用
收藏
页数：2
相关论文
共 50 条
  • [41] BTX-9341, a bifunctional degrader of CDK4 and CDK6 for glioblastoma multiforme
    Majeski, Hannah
    Chahal, Kirti
    Okano, Akinori
    Pasis, Angela
    Carlson, Casey
    Shakya, Arvind
    Liu, Qiao
    Huang, Shenlin
    Chourasia, Aparajita Hoskote
    Fung, Leah
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [42] Bromodomain inhibition reduces CDK6 expression and reverses CDK4/6 inhibitor resistance in ER plus breast cancer
    Liu, Renyan
    Pantelidou, Constantia
    Jadhav, Heta
    Shapiro, Geoffrey
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [43] Synergistic Efficacy of CDK4/6 Inhibitor Abemaciclib and HDAC Inhibitor Panobinostat in Pancreatic Cancer Cells
    Bhutkar, Shraddha
    Yadav, Anjali
    Patel, Himaxi
    Barot, Shrikant
    Patel, Ketan
    Dukhande, Vikas V.
    [J]. CANCERS, 2024, 16 (15)
  • [44] Development and characterization of a novel CDK4/6 inhibitor for the treatment of CDK4/6 dependent cancers
    O'Brien, Neil A.
    McDermott, Martina S.
    O'Boyle, Brendan M.
    Hilf, Justin A.
    Loson, Oliver
    Chau, Kevin
    Jia, Weiping
    Kamranpour, Naeimeh
    Luo, Tong
    Ayala, Raul
    Issakhanian, Shawnt
    Glaspy, John A.
    Stoltz, Brian M.
    Slamon, Dennis J.
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [45] A phase 1b study of abemaciclib, an inhibitor of CDK4 and CDK6, in combination with endocrine and HER2-targeted therapies for patients with metastatic breast cancer
    Beeram, M.
    Tolaney, S. M.
    Beck, J. T.
    Dickler, M. N.
    Conlin, A. K.
    Dees, C.
    Helsten, T. L.
    Conkling, P. R.
    Edenfield, W. J.
    Richards, D. A.
    Kambhampati, S. R. P.
    Costigan, T. M.
    Chan, E.
    Pant, S.
    Kalinsky, K.
    Burris, H. A.
    Becerra, C. H.
    Rexer, B. N.
    Puhalla, S. L.
    Goetz, M. P.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [46] Abemaciclib, a CDK4 and 6 inhibitor with unique pharmacological properties for breast cancer therapy.
    Torres-Guzman, Raquel
    Ganado, Maria Patricia
    Perez, Cecila Mur
    Marugan, Carlos
    Baquero, Carmen
    Yang, Yanzhu
    Du, Jian
    de Dios, Alfonso
    Puig, Oscar
    Lallena, Maria Jose
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [47] THE CDK4/6 INHIBITOR ABEMACICLIB IN PATIENTS WITH RECURRENT MENINGIOMA AND OTHER PRIMARY CNS TUMORS
    Coffee, Elizabeth
    Panageas, Katherine
    Young, Robert
    Morrison, Tara
    Daher, Ahmad
    Grommes, Christian
    Gavrilovic, Igor T.
    Lin, Andrew
    Miller, Alexandra
    Schaff, Lauren
    Daras, Mariza
    DeAngelis, Lisa
    Diamond, Eli
    Piotrowski, Anna
    Malani, Rachna
    Nolan, Craig
    Pentsova, Elena
    Santomasso, Bianca
    Stone, Jacqueline
    Nair, Suresh
    Mellinghoff, Ingo K.
    Kaley, Thomas
    [J]. NEURO-ONCOLOGY, 2021, 23 : 72 - 73
  • [48] Distinct CDK6 complexes determine tumor cell response to CDK4/6 inhibitors and degraders
    Xuewei Wu
    Xiaobao Yang
    Yan Xiong
    Ruitong Li
    Takahiro Ito
    Tamer A. Ahmed
    Zoi Karoulia
    Christos Adamopoulos
    Hong Wang
    Li Wang
    Ling Xie
    Jing Liu
    Beatrix Ueberheide
    Stuart A. Aaronson
    Xian Chen
    Sean G. Buchanan
    William R. Sellers
    Jian Jin
    Poulikos I. Poulikakos
    [J]. Nature Cancer, 2021, 2 : 429 - 443
  • [49] Distinct CDK6 complexes determine tumor cell response to CDK4/6 inhibitors and degraders
    Poulikakos, P.
    Wu, X.
    Yang, X.
    Xiong, Y.
    Ito, T.
    Ahmed, T.
    Karoulia, Z.
    Adamopoulos, C.
    Li, R.
    Wang, H.
    Wang, L.
    Xie, L.
    Liu, J.
    Ueberheide, B.
    Aaronson, S.
    Chen, X.
    Buchanan, S.
    Sellers, W.
    Jin, J.
    [J]. EUROPEAN JOURNAL OF CANCER, 2020, 138 : S5 - S5
  • [50] CDK6 Immunophenotype Implicates Potential Therapeutic Application of CDK4/6 Inhibitors in Urothelial Carcinoma
    Sun, Ran
    Wang, Xuemei
    Zhang, Leichao
    Gu, Yu
    Yang, Shaojuan
    Wang, Liping
    Wang, Xueju
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
12345